Impact of CRISPR in cancer drug discovery

Authors

Lawrence Lum (ORCID: https://orcid.org/0000-0002-6119-0253)
Alexis C. Komor (ORCID: https://orcid.org/0000-0001-5043-0998)
Jason Moffat (ORCID: https://orcid.org/0000-0002-5663-8586)

Institutions

The University of Texas Southwestern Medical Center (US)

Publication Details

Journal: Science
Published: 2024-10-24
DOI: https://doi.org/10.1126/science.adi6884
Citations: 5
Primary Topic: CRISPR and Genetic Engineering
Type: article
Field-Weighted Citation Impact: 1.17

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Impact of CRISPR in cancer drug discovery

Lawrence Lum, Alexis C. Komor, Jason Moffat

Oct 24, 2024

5 citations

Science

CRISPR and Genetic Engineering

1.17

article

Impact of CRISPR in cancer drug discovery

Lawrence Lum, Alexis C. Komor, Jason Moffat

October 24, 2024article en

5 citations

Abstract

No abstract available for this paper.

ScienceVol. 386(6720)

The University of Texas Southwestern Medical Center (US)

Openalex Percentile: Top 21%

CRISPR and Genetic Engineering

1.17

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Impact of CRISPR in cancer drug discovery — Lawrence Lum, Alexis C. Komor, et al. · Science (2024) | TGRS Research Map | TGRS